Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$222,848,476
-$24,545,400 QoQ
Shares Held
448,631
-19.0% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#67
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $495,549,179 across 38 Biotechnology names. VRTX ranks #1 (45.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
448,631 | $222,848,476 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
129,236 | $80,583,815 | |
| 3 | TECH |
BIO-TECHNE Corp
|
818,905 | $57,855,638 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
75,311 | $22,670,870 | |
| 5 | ARGX |
Argenx SE
|
19,088 | $17,709,273 | |
| 6 | INSM |
INSMED Inc
|
73,607 | $7,847,978 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
97,536 | $7,634,142 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
29,928 | $7,211,749 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222,848,476 | 448,631 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $247,393,876 | 554,024 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $239,312,422 | 527,864 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $210,386,657 | 537,194 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $240,643,955 | 540,530 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $291,467,481 | 601,187 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $224,563,238 | 557,644 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $214,813,940 | 461,886 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $204,636,120 | 436,585 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $138,805,653 | 332,063 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $129,991,589 | 319,476 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $111,002,084 | 319,210 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $166,526,626 | 473,208 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $145,873,628 | 462,988 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $134,956,133 | 467,332 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $147,207,925 | 508,420 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $170,256,108 | 604,195 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $174,985,081 | 670,518 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $146,649,318 | 667,802 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $111,864,663 | 616,708 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $42,094,496 | 208,771 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $36,768,968 | 171,106 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $33,198,207 | 140,468 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $57,156,629 | 210,042 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $57,178,586 | 196,957 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $37,174,214 | 156,227 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||